ByHeart Infant Formula Recalled After Possible Link to Botulism Outbreak in Infants

 


Washington, D.C. – ByHeart, the U.S. infant formula manufacturer, announced a complete and voluntary recall of all its products after health authorities detected a possible outbreak of infant botulism allegedly linked to one of its powdered formula batches.

According to a statement issued by the company, the decision was made “out of an abundance of caution and in cooperation with the U.S. Food and Drug Administration (FDA)” after several cases of botulism poisoning were confirmed in infants who consumed the formula in recent weeks.

The FDA and the Centers for Disease Control and Prevention (CDC) are investigating the source of the outbreak and are urging parents and caregivers to immediately discontinue use of any ByHeart product, regardless of the batch number or expiration date.

Health authorities warned that infant botulism is a serious illness caused by the bacterium Clostridium botulinum, whose toxins can cause muscle paralysis, respiratory distress, and, in severe cases, death. Initial symptoms include constipation, general weakness, weak crying, and feeding difficulties.

“The risk is low, but potentially fatal. That’s why we are acting with the utmost caution,” the FDA stated in its emergency advisory.

The Pennsylvania-based company affirmed that it maintains the highest production standards, although it acknowledged possible deficiencies in the microbiological control of one of the batches manufactured at its plant during the past month.

In a message released through its official social media channels, ByHeart stated that it is cooperating closely with authorities and offered full refunds to affected consumers. “Our absolute priority is the health and safety of babies and their families,” the company stated.

Previous Post Next Post